Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML

Author:

Lennerz Jochen K.1,Salgado Roberto23,Kim Grace E.4,Sirintrapun Sahussapont Joseph5,Thierauf Julia C.16,Singh Ankit1,Indave Iciar7,Bard Adam1,Weissinger Stephanie E.8,Heher Yael K.1,de Baca Monica E.9,Cree Ian A.10,Bennett Shannon11,Carobene Anna12,Ozben Tomris1314,Ritterhouse Lauren L.1

Affiliation:

1. Department of Pathology , Massachusetts General Hospital/Harvard Medical , Boston , MA , USA

2. Department of Pathology, GZA-ZNA Hospitals , Antwerp , Belgium

3. Division of Research, Peter Mac Callum Cancer Centre , Melbourne , Australia

4. Department of Pathology , University of California San Francisco , San Francisco , CA , USA

5. Pathology Informatics, Memorial Sloan Kettering Cancer Center , NY , USA

6. Department of Otorhinolaryngology, Head and Neck Surgery, German Cancer Research Center (DKFZ) , Heidelberg University Hospital and Research Group Molecular Mechanisms of Head and Neck Tumors , Heidelberg , Germany

7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) , Lisbon , Portugal

8. Alb Fils Clinics GmbH , Institute of Pathology , Göppingen , Germany

9. Pacific Pathology Partners , Seattle , WA , USA

10. International Agency for Research on Cancer (IARC), World Health Organization , Lyon , France

11. Department of Laboratory Medicine and Pathology (DLMP), Mayo Clinic , Rochester , MN , USA

12. IRCCS San Raffaele Scientific Institute , Milan , Italy

13. Medical Faculty, Dept. of Clinical Biochemistry , Akdeniz University , Antalya , Türkiye

14. Medical Faculty, Clinical and Experimental Medicine, Ph.D. Program , University of Modena and Reggio Emilia , Modena , Italy

Abstract

AbstractBackgroundLaboratory medicine has reached the era where promises of artificial intelligence and machine learning (AI/ML) seem palpable. Currently, the primary responsibility for risk-benefit assessment in clinical practice resides with the medical director. Unfortunately, there is no tool or concept that enables diagnostic quality assessment for the various potential AI/ML applications. Specifically, we noted that an operational definition of laboratory diagnostic quality – for the specific purpose of assessing AI/ML improvements – is currently missing.MethodsA session at the 3rd Strategic Conference of the European Federation of Laboratory Medicine in 2022 on “AI in the Laboratory of the Future”prompted an expert roundtable discussion. Here we present a conceptual diagnostic quality framework for the specific purpose of assessing AI/ML implementations.ResultsThe presented framework is termed diagnostic quality model (DQM) and distinguishes AI/ML improvements at the test, procedure, laboratory, or healthcare ecosystem level. The operational definition illustrates the nested relationship among these levels. The model can help to define relevant objectives for implementation and how levels come together to form coherent diagnostics. The affected levels are referred to as scope and we provide a rubric to quantify AI/ML improvements while complying with existing, mandated regulatory standards. We present 4 relevant clinical scenarios including multi-modal diagnostics and compare the model to existing quality management systems.ConclusionsAdiagnostic quality modelis essential to navigate the complexities of clinical AI/ML implementations. The presented diagnostic quality framework can help to specify and communicate the key implications of AI/ML solutions in laboratory diagnostics.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3